Juno Therapeutics, Inc. (NASDAQ:JUNO) Basic Net EPS Stands At $-2.72

0

Juno Therapeutics, Inc. (NASDAQ:JUNO) had an annual basic consolidated EPS of $-2.7157 for the period ended 2015-12-31. For the quarter ended 2015-12-31 which was on quarterly basis, the basic consolidated EPS reading was $-2.7157.

EPS from continuing operations

Juno Therapeutics, Inc. (NASDAQ:JUNO) reported $-2.7157 as the basic EPS from continuing operations for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations stood at $-2.7157 for the three-month period ended 2015-12-31.

EPS contribution from parent

From its parent company, Juno Therapeutics, Inc. (NASDAQ:JUNO) received basic EPS of $-2.7157 for the annual period ended 2015-12-31. EPS contribution from the parent company was $-2.7157 which was on quarterly basis for the period ended 2015-12-31.

Basic net EPS

A basic net EPS of $-2.72 was reported by Juno Therapeutics, Inc. (NASDAQ:JUNO) for the annual period ended 2015-12-31. For the three-month period ended 2015-12-31 which was on a quarterly basis, the company’s basic net EPS stood at $-2.72.

Consolidated diluted EPS

For the period ended 2015-12-31, $-2.7157 was reported as the annual consolidated diluted EPS reading. Consolidated diluted EPS was $-2.7157 for the quarter ended 2015-12-31.

Basic diluted EPS

Diluted EPS reading from continuing operation was $-2.7157 which was on annual basis but for the period ended 2015-12-31. From continuing operations, Diluted EPS was $-2.7157 for the quarter ended 2015-12-31.

Net diluted EPS

Net diluted EPS reading was $-2.72 for the annual period ended 2015-12-31 while the net diluted EPS for the quarterly period ended 2015-12-31 stood at $-2.72.

Diluted EPS from parent

Diluted EPS of $-2.7157 was received by Juno Therapeutics, Inc. (NASDAQ:JUNO) from its parent company which was for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, diluted EPS contribution from the parent was $-2.7157 on quarterly basis. For the annual period ended 2015-12-31, $-2.72 was posted by Juno Therapeutics, Inc. (NASDAQ:JUNO) as net basic EPS reading.

For the quarter ended 2015-12-31, basic net EPS of $-2.72 was reported. The period ended 2015-12-31 had annual average basic shares outstanding of 88.145. But it was 88.145 for the quarter ended 2015-12-31. 88.145 and 88.145 were the diluted shares outstanding for the fiscal year ended is 2015-12-31 respectively.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 1 times, 1 visits today)